Abstract
Whole-cell voltage clamp electrophysiology using glass patch pipettes (1) is regarded as the gold standard for measurement of compound activity on ion channels. Despite the high quality of the data generated by this method, in its traditional format, patch clamping has limited use in drug screening due to very low throughput. Over the years, developments in microfabrication have driven the development of planar, multi-aperture technologies that are suitable for parallel, automated patch recording techniques. Here we present detailed methods for two common applications of the planar patch technology using one of the commercially available instruments. The results demonstrate (a) the high quality of whole-cell recordings obtainable from cell lines expressing human Nav1.2 or hERG ion channels, (b) the advantages of the methodology for increasing throughput, and (c) examples of how these assays support ion channel drug discovery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391, 85–100.
Klemic, K. G., Klemic, J. F., Reed, M. A., and Sigworth, F. J. (2002) Micromolded PDMS planar electrode allows patch clamp electrical recordings from cells. Biosens. Bioelectron. 17, 597–604.
Dubin, A. E., Nasser, N., Rohrbacher, J., Hermans, A. N., Marrannes, R., Grantham, C., Van, R. K., Cik, M., Chaplan, S. R., Gallacher, D., Xu, J., Guia, A., Byrne, N. G., and Mathes, C. (2005) Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp. J. Biomol. Screen. 10, 168–181.
Tao, H., Santa, A. D., Guia, A., Huang, M., Ligutti, J., Walker, G., Sithiphong, K., Chan, F., Guoliang, T., Zozulya, Z., Saya, S., Phimmachack, R., Sie, C., Yuan, J., Wu, L., Xu, J., and Ghetti, A. (2004) Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay. Drug Dev. Technol. 2, 497–506.
Mathes, C. (2006) QPatch: the past, present and future of automated patch clamp. Expert. Opin. Ther Targets 10, 319–327.
Schroeder, K., Neagle, B., Trezise, D. J., and Worley, J. (2003) Ionworks HT: a new high-throughput electrophysiology measurement platform. J. Biomol. Screen. 8, 50–64.
Sanguinetti, M. C., Jiang, C., Curran, M. E., and Keating, M. T. (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81, 299–307.
Trudeau, M. C., Warmke, J. W., Ganetzky, B., and Robertson, G. A. (1995) HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269, 92–95.
Redfern, W. S., Carlsson, L., Davis, A. S., Lynch, W. G., MacKenzie, I., Palethorpe, S., Siegl, P. K., Strang, I., Sullivan, A. T., Wallis, R., Camm, A. J., and Hammond, T. G. (2003) Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 58, 32–45.
Guo, L. and Guthrie, H. (2005) Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation. J. Pharmacol. Toxicol. Methods. 52, 123–135.
Catterall, W. A. (1992) Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev. 72, S15–S48.
Whitaker, W. R., Faull, R. L., Waldvogel, H. J., Plumpton, C. J., Emson, P. C., and Clare, J. J. (2001) Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res. Mol. Brain Res. 88, 37–53.
Catterall, W. A. (1999) Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv Neurol. 79, 441–456.
Clare, J. J., Tate, S. N., Nobbs, M., and Romanos, M. A. (2000) Voltage-gated sodium channels as therapeutic targets. Drug Discov. Today 5, 506–520.
Bean, B. P., Cohen, C. J., and Tsien, R. W. (1983) Lidocaine block of cardiac sodium channels. J. Gen. Physiol. 81, 613–642.
Kuo, C. C. and Bean, B. P. (1994) Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol. Pharmacol. 46, 716–725.
Kuo, C. C. and Lu, L. (1997) Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br. J. Pharmacol. 121, 1231–1238.
Witchel, H. J., Milnes, J. T., Mitcheson, J. S., and Hancox, J. C. (2002) Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. J. Pharmacol. Toxicol. Methods 48, 65–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Jones, K.A., Garbati, N., Zhang, H., Large, C.H. (2009). Automated Patch Clamping Using the QPatch. In: Janzen, W., Bernasconi, P. (eds) High Throughput Screening. Methods in Molecular Biology, vol 565. Humana Press. https://doi.org/10.1007/978-1-60327-258-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-60327-258-2_10
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-257-5
Online ISBN: 978-1-60327-258-2
eBook Packages: Springer Protocols